February 28, 2017 / 6:29 AM / 5 months ago

BRIEF-Vistin Pharma posts Q4 negative EBITDA of NOK 1.5 million

1 Min Read

Feb 28 (Reuters) - Vistin Pharma Asa

* Recorded total revenue and income of 93.6 million Norwegian crowns ($11.19 million) in Q4 of 2016, compared to 104.5 million crowns in Q4 of 2015

* Adjusted EBITDA for Q4 ended at minus 1.5 million crowns, while the full-year figure showed a positive 29.5 million crowns Source text for Eikon: Further company coverage: ($1 = 8.3617 Norwegian crowns) (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below